Teclistamab is a breakthrough drug in the field of cancer treatment that has recently been approved for use in India. Teclistamab in India is effective in patients who have not responded to other treatments, including immunomodulatory drugs and proteasome inhibitors. It can target cancer cells while sparing healthy tissues, thereby minimizing side effects commonly associated with traditional treatments. The drug also showed a manageable safety profile, with the most common side effects being anemia, neutropenia, and cytokine release syndrome. At Impomed Healthcare we are committed to ensuring that cutting-edge treatments like Teclistamab are accessible to all patients in need.